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Since its inception more than 30 yearsago, the baculovirus expression vector
system (BEVS) has been used prolifically
to produce heterologous proteins for
research and development. In the cell, a
cornerstone of biological activity are mul-
tiprotein complexes, catalyzing essential
functions. BEVS has been uniquely suc-
cessful to unlock such complex assem-
blies for high-resolution structural and
functional analysis. Synthetic biology
approaches have been implemented to
optimize multigene assembly methods,
accelerating upstream processes. Special-
ized baculoviral genomes are being cre-
ated with functions tailored to enhance
production of particular target protein
classes. Here we comment on current
and emerging developments in the field
and their potential to accelerate protein
complex research.
Introduction
In eukaryotes, protein complexes com-
posed of many subunits carry out most
essential physiological processes, and are
intensely researched today. Some complexes
are highly abundant in cells, and can be
purified with relative ease from endogenous
source material in the quality and quantity
required for high resolution analysis of their
structure and mechanism. Proteasomes,
ribosomes, globins and RNA polymerases
are impressive examples. However, this
appears to the exception rather that the rule.
Our insight into the overwhelming com-
plexity of cellular biology increases rapidly,
and it appears that the majority of the pro-
tein complexes which function in our body
are characterized by low abundance and,
moreover, by compositional heterogeneity,
which thoroughly complicates or even rules
out their extraction from tissue.
Recombinant production affords a con-
venient means to resolve this bottleneck.
Consequently, recombinant protein pro-
duction has become a dominant force for
producing protein specimens today. A
number of expression systems exist, utiliz-
ing prokaryotic or eukaryotic host organ-
isms, or also cell-free systems, each with
their own merit.1,2 Among these, heterolo-
gous expression in mammalian cells or
insect cells, respectively, have emerged as
methods of choice for eukaryotic protein
specimens, exemplified by a rapidly grow-
ing number of entries in the Protein Data
Bank (PDB) using these expression hosts.
Mammalian expression has been determi-
nant for the production of large, multi-
domain, sometimes highly glycosylated
eukaryotic cell surface receptors and their
supramolecular assemblies.3 For eukaryotic
multiprotein complexes with many subu-
nits, the baculovirus expression vector sys-
tem (BEVS) has turned out to be
particularly powerful, unlocking the struc-
ture and mechanism of many important
complex assemblies that had remained
inaccessible to detailed analysis before-
hand.4,5 Today, baculovirus is prolifically
used to accelerate a wide range of applica-
tions in the life sciences (Fig. 1).
Baculovirus Expression: The
Origins
The first report illustrating the enor-
mous potential of a recombinant
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baculovirus was published in 1983. Max
Summers, Gale Smith and colleagues used
Autographa californica multiple nucleo-
polyhedrovirus (AcMNPV) to express
recombinant human INF-b.6 They have
substituted the gene of a viral protein, pol-
yhedrin (polh), with the human gene
encoding for INF-b. Since this hallmark
study, the procedures were step-by-step
improved to render this expression system
user friendly, involving engineering of
recombinant viruses and development of
time and cost-effective protocols for pro-
tein production in insect cell cultures.
The original procedure to generate
recombinant baculoviruses was based on
homologous recombination into the polh
locus, in insect cells, between a viral
genome and a transfer plasmid harboring
the gene(s) of interest. This was not overly
efficient, and required inspection of
infected cells by eye to identify the polh
deficient phenotype which would lack
granular shapes that were birefringent.
This approach was much improved when
suitable restriction enzymes were identi-
fied to cleave the baculovirus within the
polh locus, thus linearizing the baculoviral
genome and eliminating non recombined
genomes.7 Now, recircularization of the
viral genome, and thus live and infectious
baculovirus generation depended on the
success of heterologous gene integration,
which still occurred by homologous
recombination in the insect cell which
thereby invited they own destruction, after
releasing recombinant baculovirions to
infect further cells in the culture. This was
already a much improved procedure, and
in the hands of experienced users could be
applied relatively straight-forwardly in the
research laboratory.
A breakthrough which propelled bacu-
lovirus expression and rendered it genu-
inely accessible to many laboratories was
the construction of an artificial chromo-
some (BAC) made up of the baculoviral
genome supplemented by DNA elements
that enabled stable propagation of this
BAC at very low copy number (1-2) in
E.coli cells. This approach profoundly
simplified the generation of recombinant
baculovirus, removing laborious and time
consuming interventions to clonally iso-
late producer viruses by plaque-purifica-
tion (Fig. 2A). The first and to date most
popular approach for inserting foreign
genes into the BAC relies on Tn7-
mediated transposition.8 This
BAC/Tn7 entry system is used by
several popular systems including
the classical Bac-to-BacTM system
from Invitrogen / Life sciences,
and also by the more recent Multi-
Bac system which in recent years
became the lead technology for
BEVS-mediated production of
multiprotein complexes for many
applications in academia and
industry.4,9-11 In the BAC/Tn7
approach, prior to the production
of the recombinant virus, the gene
of interest is cloned into a transfer
plasmid harboring the expression
cassette which is flanked by short
DNA sequences representing the
right and left arms of the Tn7
transposon. The sequenced transfer
plasmid is then transformed into
custom E. coli DH10 cells which
contain the BAC and in addition a
helper plasmid that supplies the
Tn7 transposase needed to carry
out the transposition into the Tn7
attachment site that is present on
the BAC. The resulting recombinant BAC
DNA (bacmid) is extracted and can be
verified easily by a PCR reaction with
appropriate primers. The recombinant
bacmid DNA is then used to transfect
insect cells using a lipidic tranfection
reagent in small cell cultures. Infected cells
then realize the viral genome, giving rise
to live baculovirions that can then be used
to infect larger cell cultures to produce
and purify the protein specimen of interest
(Figs. 1, 2).
Numerous variations to the BAC
approach have been implemented. A BAC
was constructed carrying a disabling muta-
tion in an essential gene (ORF1692)
which impairs virus replication. This det-
rimental mutation is repaired when the
mutant BAC is co-transfected with a
transfer plasmid containing the expression
cassette and a wild type copy of the
mutated gene. Homologous recombina-
tion between the viral DNA and the trans-
fer plasmid restores replication, eliminates
the bacterial replicon in the polyhedrin
locus, and integrates the gene of interest
(Figs. 2A, B). As replication of not recom-
bined viral genomes is ruled out here,
clonal selection procedures are not
Figure 1. Baculovirus Expression Vector System BEVS. The BEVS can be conceptualized on 3 levels. DNA ele-
ments comprising genes of interest, promoters, terminators, transcriptional enhancers and others are com-
bined with plasmid backbone modules into (multi)gene expression cassettes on transfer plasmids (left).
Transfer plasmids are then integrated into a baculoviral genome by using transposition or recombination
methods to yield a composite baculoviral genome containing all heterologous DNA elements (center).
Recombinant baculovirus containing the composite genome is then used to infect insect cell cultures to
produce materials for a multitude of down-stream applications (right). All three levels, transfer plasmid
assembly, the baculoviral genome and the expression host cell, can be engineered by exploiting powerful
synthetic biology tools, for optimizing and maximizing system performance.
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Figure 2. Baculovirus multigene expression tools. (A) Flowcharts for production of recombinant viruses and protein expression protein production using
either Tn7-mediated transposition (top) or homologous recombination (bottom) are shown. (B) Construction of recombinant baculovirus genomes are
shown in a schamtic representation. Transposition of an expression cassette embedded between the Tn7L and Tn7R DNA sequence into the Tn7 attach-
ment site of the baculoviral genome is illustrated on the left (from Ref. 8). Homologous recombination combining a linearized baculoviral DNA genome
and a transfer plasmid for inserting the gene(s) of interest is shown on the right (from Ref. 13). Most currently used viral genomes contain deletions of
the genes encoding for chiA and V-cath, a chitinase and protease, respectively, shown to be detrimental for protein production and stability. This locus
can be used to insert foreign genes including ﬂuorescent makers such as YFP or the DsRed protein to monitor virus performance and protein production.
A LoxP site-speciﬁc recombination site, inserted at this position, allows to generate composite viral genomes by in vivo Cre-LoxP fusion in E. coli with a
customized transfer plasmids containing a conditional replication origin.9 (C) Multigene assembly DNA tools used in tandem recombineering (TR) are
shown. So-called Acceptor and Donor plasmids contain multiple cloning sites (MCS) to insert genes of interest by conventional or samless cloning meth-
ods of choice. Genes are placed typically under the control of late baculoviral promoters (PH or p10) and eukaryotic polyadenylation signals (PH ter,
SV40 or HSVtk). Acceptors and Donors possess multiplications modules (gray rectangles) located on both sides of the expression cassette as well a loxP
site (circle ﬁlled in orange). (D) For multi-gene construct generation using multiplication modules, individual expression cassettes are excised by diges-
tion with a pair of endonucleases and inserted via compatible restriction sites into the multiplication module of a progenitor plasmid. Following ligation,
the restriction sites used for integration are eliminated and multiplication can be repeated iteratively using the intact multiplication module in the
inserted cassette.9 Plasmids thus charged with several genes of interest can be fused by Cre mediated recombination via the LoxP sites. Acceptors have
a regular origin of replication (ori ColE1), whereas donors have a conditional origin derived from R6Kg phage (ori R6Kg), facilitating multigene
assembly.21,30,39
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required. This effectively generates a time-
saving one-step procedure.12-14 Ready-to-
use linearized DNA Baculovirus DNAs
are available commercially (for example
OET’s FlashBac) but can also be prepared
with reasonable cost and effort from
appropriate bacterial strains.13,15 This
approach lends itself to automation and
thus to high-throughput applications
when a large number of constructs are to
be screened in expression tests. Automa-
tion of the BAC/Tn7 approach is also pos-
sible, but far more laborious as many more
steps to prepare bacmid DNA have to be
considered. Recently, a set of transfer plas-
mids, called OmniBac, combines the
options to use both the Tn7/BAC system
and classical heterologous recombination
approach using the same entry reagents,
thus allowing exploitation of the advan-
tages of either system without having to
reclone the heterologous genes of
interest.16,17
Protein expression has drawn vast ben-
efit from advances in synthetic biology
and recombineering technologies that
allow targeted modification of the baculo-
virus genome.10,16,18 Most platforms for
virus production now rely on engineered
viral genomes in which genes considered
to be detrimental for protein production
or stability have been deleted. Among the
first genes that were removed following
the original polh deletion are v-cath and
chiA, that encode a cathepsin protease and
a chitinase, respectively, which are
involved in the liquefaction of infected
larvae.9,19 This was followed up by elimi-
nation of further genes (p10, p26, p73).20
The loci for v-cath and chiA are juxta-
posed in the viral genome, and this region
has been utilized to insert genes encoding
maker proteins such as yellow fluorescent
protein (YFP) or sea anemone red fluores-
cent protein (dsRed), as well as chaperones
or post-translational modification
enzymes by site specific recombination,
thus generating novel functionalized
genomes (Fig. 2B). Additions can include
kinases, phosphates as well as enzymes
that allow to synthetize complex carbohy-
drates found on many secreted proteins of
mammalian origin.10,21,22
Synthetic biology is emerging as a pro-
found game-changer in the life sciences
and synthetic biology approaches are
opening up entirely new avenues that may
transform recombinant protein produc-
tion in the future. We are only beginning
to scratch at the surface of what is possi-
ble. The design and synthesis of the entire
one megabase Mycoplasma mycoides bacte-
rial genome has been achieved.23 We now
have all tools in hand to entirely rewrite
the 130 kilobases baculovirus genome and
create synthetic versions comprising only
DNA elements essential for laboratory
applications. Synthetic baculoviral
genomes with improved genetic stability
and customized for optimal protein pro-
duction of specific classes of proteins at
high levels, will benefit for applications
ranging from drug discovery to industrial
protein therapeutics production.16
Strategies for Protein Complex
Production
Expression levels and solubility of
recombinant proteins expressed by BEVS
can range from a few micrograms to hun-
dreds of milligrams per liter, and cannot
be predicted. Typically, constructs need to
be modified by truncation, mutation or
deletion of low complexity regions. The
use of adapted affinity tags is often the
only means to obtain pure protein.24,25
Numerous pipelines for expression screen-
ing and protein production at medium to
large scale (250 ml-6L) have been
established.15,26,27
Preparation of multiprotein complexes
in particular for structural biology applica-
tions has its own challenges and specifics.
Sometimes, functional subunits of a given
complex can be produced in isolation.
Then, protein complexes may be assem-
bled in vitro from these individually
expressed subunits. Reconstitution meth-
ods are particularly useful when the com-
plex is short-lived and thus cannot be
purified intact. One or several compo-
nents may not be proteinaceous, such as
in protein-DNA or protein-RNA com-
plexes or enzymatic assemblies with co-
enzymes and prosthetic factors, or when a
small-molecular ligand is required to sta-
bilize a complex.28 Here, components are
expressed individually, and revised expres-
sion experiments can be easily accommo-
dated to modify the composition of the
complex by replacing one or more subu-
nits by mutant versions for example to
define protein functional domains, opti-
mize solubility or to reduce conforma-
tional heterogeneity by eliminating
disordered regions that often interfere
with high-resolution structural studies.
In many cases, however, in vitro recon-
stitution is not applicable as individual
subunits of a complex often cannot be
expressed and manipulated in absence of
their protein partners. Then, co-expres-
sion is a vital prerequisite.29 In BEVS, this
can be achieved by co-infection with mul-
tiple viruses, each expressing a single poly-
peptide, or, alternatively, by infection
with a single virus driving the expression
of all foreign genes required. If a large
number of proteins need to be co-
expressed, a combination of both
approaches can be applied.4,30 This strat-
egy has been particularly successfully for
the reconstitution, structural and func-
tional analysis of large multi-protein com-
plexes including large human general
transcription factors TFIID 31,32 and
TFIIH33,34 and 2 essential multiprotein
components of the gene regulation
machinery.
Co-expression of many gene products
from several viruses each encoding for a
single or limited number of heterologous
proteins exploits the capacity of insect cells
to be simultaneously infected by multiple
viruses. This approach affords a certain
flexibility to adjust protein expression
ratios by controlling the multiplicity of
infection (MOI) of the individual viruses
which are administered, and has been
used successfully for mapping protein-
protein interactions, and for providing
additional factors for post-translational
modifications and chaperones for enhanc-
ing proper folding. Co-infection can work
reasonably well for small-scale experi-
ments when a small number (2-3) baculo-
viruses are added, but scale-up is
inefficient and logistically demanding, in
particular for the production of complex
assemblies that would require co-infection
of a large number of viruses, and viral
titers for all of these would need to be
carefully gauged. The uptake of the indi-
vidual viruses by the cells in an infected
culture will follow a Poisson distribution,
resulting in subpopulations of cells
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infected by subsets of viruses.35 Further-
more, it was shown that excessive viral
load can inhibit protein expression.36
Using a single viral genome that contains
all heterologous genes circumvents these
issues, thus ensuring co-expression of all
heterologous genes in every cell in an
infected culture. Several early baculovirus
transfer plasmids were designed for
accepting 2-4 genes (pFastBacTM Dual
from Invitrogen / Life Sciences, and
pAcUW51, pAcAB, pAcAB4.37,38
A theoretically unlimited number of
heterologous genes can be co-expressed by
the more recent MultiBac system, which
exploits a method called tandem-recom-
bineering (TR) based on seamless gene
integration by sequence and ligation inde-
pendent cloning techniques into an array
of small transfer plasmid modules which
are then conjoined by site-specific recom-
bination using the Cre-Lox fusion reac-
tion.39 Multigene expression cassettes are
then inserted into the MultiBac baculovi-
ral genome by Tn7 transposition into a
Tn7 attachment site (in the polh locus)
and by site-specific recombination into a
LoxP site on the viral backbone (in the v-
cath-chiA locus) (Fig. 2B).9,21 A series of
transfer plasmids were developed to facili-
tate multigene cassette assembly
(Figs. 2C, D). A large and growing set of
tools now exist to assemble DNA elements
into large functional multigene circuits,
including homing endonuclease based
fragment assembly, one-step isothermal in
vitro recombination (Gibson cloning), or
restriction free (Rf) cloning to name a
few39,40,41 all of which can be used for
multigene expression with the MultiBac
system.
In case of complexes with many differ-
ent subunits or containing large proteins,
the size of the insert and clustering of
identical promoter and terminator
sequences may lead to genetic instability
of the recombinant beculoviral genome,
resulting in deletions notably of the
inserted foreign DNA. This can be
avoided by rigorously adhering to virus
amplification protocols designed to mini-
mize such damage.21 Alternatively, heter-
ologous genes can be spread over multiple
insertion sites in the baculoviral genome
by iterative homologous recombination
steps carried out on a BAC in E.coli
cells.42,43 Applying these strategies can sig-
nificantly increase the number of genes
that can be co-expressed while preserving
the stability of the viral genome.
Stoichiometry of Complex
Subunits
Assembly and activity of cellular multi-
protein complexes critically depends on
correct stoichiometry of the subunits pres-
ent in the complex. In the cell, elaborate
mechanisms involving chaperones, assem-
bly factors and transport between cellular
compartments exist that assist and regulate
complex assembly. A recombinant expres-
sion experiment typically aims at substan-
tial overexpression in a heterologous host
cell, in which corresponding mechanisms
may or may not exist, but will likely fail to
cope with very high level expression of the
foreign proteins. This challenge often
needs to be addressed during expression
and during purification by tight control of
the proper stoichiometry of the individual
subunits that make up the complex.
Both for complexes reconstituted in
vitro and for complexes assembled in situ
within the expression host cell, the desired
physiological complex will need to be sep-
arated from excess subunits and partially
assembled sub-complexes, that would oth-
erwise give rise to heterogenous sample
preparations impeding down-stream
applications, notably structural and mech-
anistic analyses that require ultra-pure
sample. Purification schemes typically
combine orthogonal techniques in a
sequential manner that has to be custom-
ized with care to yield physiological
assemblies that are homogenous in com-
position.44 On the other hand, it may be
essential to tightly control the amounts of
subunits already when they are expressed
for successful complex assembly, prior to
extraction. This sometimes imposing chal-
lenge was recently addressed in an elegant
fashion by adapting a strategy used by cer-
tain viruses in nature to realize their prote-
ome. For example Coronavirus expresses
its gene product repertoire from 2 large
open reading frames that give rise to poly-
proteins that are co-translationally proc-
essed by highly specific proteases, also
encoded in the ORFs, into the individual
protein components. A recombinant
approach which recapitulates this strategy
was implemented in the MultiBac system
recently, exploiting the action of tobacco
etch virus (TEV) protease to process a syn-
thetic polyprotein that was inserted into
the MultiBac baculoviral genome by
means of a customized transfer plas-
mid.11,45 This approach, ComplexLink,
was successfully applied to produce, for
the first time, influenza polymerase that
could be crystallized unlocking the atomic
structure of this complex which has
remained elusive for decades.46
Baculovirus Expression: Stay
tuned!
Baculovirus-mediated production of
heterologous proteins in insect cells has
made come a long way since its inception
in the Summers lab many years ago.47,48
Proteins for a wide range of applications,
in basic and applied research, from struc-
tural biology to vaccinology have benefit-
ted substantially from this powerful and
versatile system. Many proteins and pro-
tein complexes were produced, often for
the first time, by BEVS, in the quality and
quantity to enable high resolution struc-
tural ad mechanistic analysis, advancing
fundamental insight and accelerating drug
discovery. Much has been done over the
years to develop improved reagents and
robust protocols, which already allow effi-
cient application of the system also by
non-specialist users, and BEVS is firmly
established a work-horse for eukaryotic
protein production in many laboratories,
in academia and industry. Improved viral
backbones with customized functionalities
for particular protein classes and applica-
tions are being developed, compellingly
undersocirng the enormous potential of
this system at the forefront of life science
research.
Conceptually, BEVS can be understood
as a system operating at 3 distinct levels, all
of which are amenable to optimization by
engineering (Fig. 1). The first level is the
transfer reagents which should enable rapid
and flexible assembly of multicomponent
gene expression circuits, ideally in a highly
parallelized, automated manner suited
in a robotics enviornment. Promoters,
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terminators, gene boundaries and affinity
tags should be freely exchangable at this
level, with minimal investment for the sci-
entists carrying out the experiment. Meth-
ods from synthetic biology are essential for
achieving this objective, and are being suc-
cessfully implemented in BEVS, substan-
tially increasing throughput. Moreover,
gene synthesis has become thoroughly
affordable, effectively multiplying the
options to design and lead to success multi-
parameter expression experiments.
The baculoviral genome constitutes the
second level in this concept. The benefit of
modifying the baluloviral genome was
already evident very early on, when the
polh gene was removed from the viral
backbone. Before, recombinant baculovi-
rus had to be identifed by a specialist user
observing the loss of occluded virus pheno-
type in infected cells, which occurred with
very low efficiency. This improved consid-
erably when the polh locus was disrupted,
and dramatically when the baculoviral
genome was linearized by endonuclease
cleavage in the polh locus. The polh dele-
tion was soon followed by further knock-
outs of genes non-essential in laboratory
culture, which exhibited a negative effect
recombinant protein production, notably
v-cath and chiA, and others. Today, with
the advent of powerful technologies to
assemble large DNAs, the complete de
novo synthesis of customized baculoviral
genomes, devoid of unnecessary or detri-
mental elements becomes a genuine possi-
bility. These synthetic baculoviral genomes
containing multiple helper functions such
as chaperones and modifiers and character-
ized by improved genomic stability, can be
tailored to specific applications, for opti-
mized, maximum level recombinant
expression of target proteins.
Genome engineering does not need to
be restricted to the baculovirus. Much
effort is being devoted currently in the
community to the improvement of the
characteristics of bacterial host organisms,
with major ongoing synthetic biology
genome rewiring efforts aimed at generat-
ing new and improved chassis for a wide
variety of purposes.49 The number of
available cell types for BEVS pale to insig-
nificance when compared to the very large
number of E.coli strains and engineered
variants that are at disposal for
recombinant expression in this prokary-
otic host. Undoubtedly, it is much more
demanding to engineer a eukaryotic cell.
The advent of powerful genome engineer-
ing tools, notably CRISPR/Cas has revo-
lutionized eukaryotic genome engineering
with transformative potential.50 We antic-
ipate that these technologies will be pro-
fusely exploited in the near future to
extend optimization to the host cell
genome, to create specialized cell strains
with defined functionalities. Coupled to
proteomics and metabolic flux analyses
during heterologous expression, genome
engineering could be likewise applied to
eliminate negative factors in the host cell
genome, by targeted deletions ideally in
high-throughput. Moreover, helper func-
tionalities such as chaperones and modi-
fiers, but also selected components of a
protein complex under investigation or
even complete complexes could then be
outsourced conveniently from the baculo-
virus to the host cell genome. This could
open entirely new possibilities for drug
discovery, greatly accelerating research
and progress. For instance, in the pharma-
ceutical industry, hundreds of kinases are
produced, often with baculoviral systems,
and many remain problematic and rely on
accessory factors. Multiprotein membrane
protein targets are increasingly in focus,
and are basically not accessible with avail-
able methods. Moreover, a major focus in
the industrial biotechnology community
is on assembling and testing synthetic
metabolic circuits and signaling cascades,
for which the here described technologies
may be uniquely useful. We expect that
engineering on all levels will ever improve
and optimize this versatile and powerful
expression system, enabling researchers to
address the most complex question in the
biology of health and disease states in the
years to come.
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